ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 637505 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 637505; 2) Community: the network communities that were significantly associated with the response to NSC 637505; 3) Molecule: the relationships between components within communities and NSC 637505; 4) MDR: the compounds that were significantly associated with the NSC 637505.

NSC Compound Enrichment Correlation
NSC 666113 Null 0.00792181575650983 0.38594096
NSC 707465 2-Butenoic acid, 4-[[4,5-dichloro-2-[[[[2-(1-pyrrolidinyl)cyclohexyl] (methyl)amino]carbonyl]methyl]phenyl]amino]-4-oxo-, methyl ester, (1S,2S)- 0.00792181575650983 0.26832183
NSC 709100 Null 0.00792181575650983 0.23213199
NSC 710779 Null 0.00792181575650983 0.35860627
NSC 228132 Benzofurazan, 5-nitro-6-(1-piperidinyl)-, 1-oxide 0.00792181575651 0.14161128
NSC 2805 2,2',5,5'-Tetrahydroxy-4,4'-dimethylbiphenyl 0.00792181575651 0.31046636
NSC 603086 2-Butene, 2,3-dibromo-1,4-bis[(3,4-dichloro-2,5-dihydro- 2-oxofuran-5-yl)oxy]-, (Z)- 0.00792181575651 0.41041491
NSC 617823 4-Morpholinepentanoic acid, .alpha.-(phenylmethylene)- .beta.-oxo-, ethyl ester, hydrochloride 0.00792181575651 0.37920998
NSC 619102 4-Methoxy-1,5-benzothiazepine-1,1-dioxide 0.00792181575651 0.18723649
NSC 623436 TGF.alpha.-PE40 0.00792181575651 -0.24032514
Total:70  Current:17    [First] [Prev] [Next] [Last]